Marshall Wace North America’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-18,591
| Closed | -$400K | – | 1445 |
|
|
2020
Q4 | $400K | Buy |
+18,591
| New | +$400K | ﹤0.01% | 1124 |
|
|
2018
Q4 | – | Sell |
-137,947
| Closed | -$13.8M | – | 1459 |
|
|
2018
Q3 | $13.8M | Sell |
137,947
-2,367
| -2% | -$236K | 0.09% | 177 |
|
|
2018
Q2 | $9.97M | Sell |
140,314
-188,546
| -57% | -$13.4M | 0.06% | 334 |
|
|
2018
Q1 | $34.2M | Buy |
328,860
+141,173
| +75% | +$14.7M | 0.17% | 141 |
|
|
2017
Q4 | $18.9M | Buy |
187,687
+135,014
| +256% | +$13.6M | 0.1% | 234 |
|
|
2017
Q3 | $1.84M | Sell |
52,673
-158,263
| -75% | -$5.54M | 0.01% | 815 |
|
|
2017
Q2 | $5.06M | Sell |
210,936
-36,339
| -15% | -$872K | 0.04% | 496 |
|
|
2017
Q1 | $6.92M | Buy |
+247,275
| New | +$6.92M | 0.05% | 330 |
|